US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 3, 2018 (8 years ago)

Cyclophosphamide 50 mg cap NDC 00054-0383-25 28 days supply

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls.

What was recalled

Cyclophosphamide 50 mg cap NDC 00054-0383-25 28 days supply

Recalling firm
Kroger Specialty Pharmacy, Inc.
NDC code
00054-0383-25
Origin
MS, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0785-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cyclophosphamide recalls

See all
Class I · High risk Ongoing

Cyclophosphamide for Injection

Reason Presence of Particulate Matter; identified as stainless steel

Sunny Pharmtech Inc. NDC 81298-8114-1 D-0744-2026
Class I · High risk Ongoing

Cyclophosphamide for Injection

Reason Presence of Particulate Matter; identified as stainless steel

Sunny Pharmtech Inc. NDC 81298-8112-1 D-0743-2026
Class II · Moderate risk Ongoing

Cyclophosphamide Injection 500 mg/5 mL

Reason cGMP deviations: Temperature excursion during transportation.

Sandoz Inc NDC 0781-3528-75 D-0651-2025
Class III · Low risk Terminated

Cyclophosphamide for Injection

Reason Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

X-Gen Pharmaceuticals Inc. NDC 39822-0255-01 D-0434-2024
Class III · Low risk Terminated

Cyclophosphamide for Injection

Reason Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

X-Gen Pharmaceuticals Inc. NDC 39822-0250-01 D-0433-2024